Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
372 USD | -0,62 % | -5,82 % | +21,36 % |
Resumen de negocios
Número de empleados: 5 900
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Oncology
31,1
%
| 468 | 32,0 % | 587 | 31,1 % | +25,50 % |
Other
21,5
%
| 297 | 20,3 % | 405 | 21,5 % | +36,35 % |
Metabolic
20,0
%
| 245 | 16,8 % | 377 | 20,0 % | +54,01 % |
Cardiology
10,3
%
| 175 | 12,0 % | 194 | 10,3 % | +10,91 % |
Antiviral and Anti-infective
8,7
%
| 118 | 8,1 % | 163 | 8,7 % | +38,36 % |
Central Nervous System
8,5
%
| 158 | 10,8 % | 160 | 8,5 % | +1,34 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
98,0
%
| 1 431 | 98,0 % | 1 848 | 98,0 % | +29,17 % |
International
2,0
%
| 29 | 2,0 % | 38 | 2,0 % | +29,17 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 67 | 01/07/92 |
Kevin Brady
DFI | Director of Finance/CFO | 49 | 01/11/18 |
Jesse Geiger
PSD | President | 49 | 01/10/07 |
Brandon Ebken
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/21 |
Daniel O’Leary
CTO | Chief Tech/Sci/R&D Officer | - | - |
Reinilde Heyrman
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/09/17 |
Susan Burwig
COO | Chief Operating Officer | 61 | 01/08/93 |
Stephen Ewald
CMP | Compliance Officer | 54 | 01/06/12 |
Lauren Morris
IRC | Investor Relations Contact | - | - |
Todd Meyers
SAM | Sales & Marketing | - | 01/08/13 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Fred Davenport
BRD | Director/Board Member | 72 | 13/08/18 |
August Troendle
CEO | Chief Executive Officer | 67 | 01/07/92 |
Director/Board Member | 64 | 13/08/18 | |
Robert Kraft
BRD | Director/Board Member | 53 | 01/07/16 |
Brian Carley
BRD | Director/Board Member | 70 | 01/07/16 |
Director/Board Member | 62 | 16/01/23 | |
Ashley Keating
BRD | Director/Board Member | 42 | 17/05/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 31 053 758 | 25 355 644 ( 81,65 %) | 70 573 ( 0,2273 %) | 81,65 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
VTV THERAPEUTICS INC. 5.55% | 134 938 | 5.55% | 3 175 091 $ |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+21,36 % | 11,6 mil M | |
-1,42 % | 41,35 mil M | |
+42,15 % | 40,38 mil M | |
+1,97 % | 39,05 mil M | |
-14,19 % | 26,67 mil M | |
+1,82 % | 24,07 mil M | |
-24,55 % | 18,36 mil M | |
-4,07 % | 11,68 mil M | |
+8,20 % | 11,15 mil M | |
-19,49 % | 9778,89 M |
- Bolsa de valores
- Acciones
- Acción MEDP
- Empresa Medpace Holdings, Inc.